Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.40 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.40 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.40 |
| ▸ | FLT1 | P17948 | 1/20 | 0.40 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6502928 | 0.90 | SMN1; SMN2 (0.45) | SMN1; SMN2ALDH1A1KMT2AL3MBTL1LMNA | |
| SCHEMBL6488469 | 0.87 | SMN1; SMN2 (0.43) | SMN1; SMN2ALDH1A1KMT2AL3MBTL1MEN1 | |
| SCHEMBL6487920 | 0.83 | SMN1; SMN2 (0.45) | SMN1; SMN2ALDH1A1KMT2AL3MBTL1LMNA | |
| SCHEMBL7131566 | 0.80 | KMT2A (0.44) | SMN1; SMN2ALDH1A1KMT2AL3MBTL1LMNA | |
| SCHEMBL6499184 | 0.76 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1KMT2AMEN1KDM4E | |
| SCHEMBL6489011 | 0.76 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1KMT2AL3MBTL1MEN1 | |
| SCHEMBL8268147 | 0.75 | LMNA (0.45) | SMN1; SMN2ALDH1A1KMT2AL3MBTL1LMNA | |
| SCHEMBL6829590 | 0.74 | L3MBTL1 (0.45) | SMN1; SMN2ALDH1A1KMT2AL3MBTL1LMNA | |
| SCHEMBL6829591 | 0.74 | L3MBTL1 (0.45) | SMN1; SMN2ALDH1A1KMT2AL3MBTL1LMNA | |
| SCHEMBL8128216 | 0.74 | KMT2A (0.56) | SMN1; SMN2ALDH1A1KMT2AL3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050014812-A1 | Benzimidazole compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-01-20 | — | — | US | disclosed |
| WO-2004108686-A2 | BENZIMIDAZOLE COMPOUNDS HAVING HYPOGLYCEMIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-12-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014812-A1 | Benzimidazole compounds | SLC5A1, SLC5A2, G6PD | SMN1; SMN2 1128/4885ALDH1A1 96/4885KMT2A 561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.